Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nazha Hamdani

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
Circulation. Heart Failure|July 27, 2023
Inflammation in HFpEF: Crucial or Ancillary?Roua Hassoun, Nazha Hamdani
Biophysical Reviews|May 17, 2017
A change of heart: oxidative stress in governing muscle function?Martin Breitkreuz, Nazha Hamdani
Circulation|May 28, 2013
Myocardial titin and collagen in cardiac diastolic dysfunction: partners in crimeNazha Hamdani, Walter J Paulus
Journal of the American Heart Association|January 17, 2025
Between the Beats: Unraveling Diagnostic, Therapeutic Challenges, and Sex Differences in Heart Failure's Gray ZoneNazha Hamdani, Ibrahim El-Battrawy
Current Pharmaceutical Biotechnology|January 28, 2012
Alteration of the beta-adrenergic signaling pathway in human heart failureNazha Hamdani, Wolfgang A Linke
Circulation Research|March 15, 2014
Gigantic business: titin properties and function through thick and thinWolfgang A Linke, Nazha Hamdani
Current Treatment Options in Cardiovascular Medicine|November 27, 2010
Treatment of heart failure with normal ejection fractionNazha Hamdani, Walter J Paulus
European Heart Journal|July 5, 2020
Regression of left ventricular hypertrophy with SGLT2 inhibitorsFrancesco Paneni, Sarah Costantino, Nazha Hamdani
European Journal of Heart Failure|December 30, 2020
A mechanistic rationale for the investigation of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction. Letter regarding the article 'Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial'Steffen Pabel, Nazha Hamdani, Samuel Sossalla
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 22, 2009
Lack of specificity of antibodies directed against human beta-adrenergic receptorsNazha Hamdani, Jolanda van der Velden
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
Circulation. Heart Failure|July 27, 2023
Inflammation in HFpEF: Crucial or Ancillary?Roua Hassoun, Nazha Hamdani
Biophysical Reviews|May 17, 2017
A change of heart: oxidative stress in governing muscle function?Martin Breitkreuz, Nazha Hamdani
Circulation|May 28, 2013
Myocardial titin and collagen in cardiac diastolic dysfunction: partners in crimeNazha Hamdani, Walter J Paulus
Journal of the American Heart Association|January 17, 2025
Between the Beats: Unraveling Diagnostic, Therapeutic Challenges, and Sex Differences in Heart Failure's Gray ZoneNazha Hamdani, Ibrahim El-Battrawy
Current Pharmaceutical Biotechnology|January 28, 2012
Alteration of the beta-adrenergic signaling pathway in human heart failureNazha Hamdani, Wolfgang A Linke
Circulation Research|March 15, 2014
Gigantic business: titin properties and function through thick and thinWolfgang A Linke, Nazha Hamdani
Current Treatment Options in Cardiovascular Medicine|November 27, 2010
Treatment of heart failure with normal ejection fractionNazha Hamdani, Walter J Paulus
European Heart Journal|July 5, 2020
Regression of left ventricular hypertrophy with SGLT2 inhibitorsFrancesco Paneni, Sarah Costantino, Nazha Hamdani
European Journal of Heart Failure|December 30, 2020
A mechanistic rationale for the investigation of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction. Letter regarding the article 'Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial'Steffen Pabel, Nazha Hamdani, Samuel Sossalla
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 22, 2009
Lack of specificity of antibodies directed against human beta-adrenergic receptorsNazha Hamdani, Jolanda van der Velden
Pageof 18